GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Other Gross PPE

Akeso (AKESF) Other Gross PPE : $464.7 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Akeso Other Gross PPE?

Akeso's Other Gross PPE for the quarter that ended in Jun. 2024 was $464.7 Mil.

Akeso's quarterly Other Gross PPE declined from Jun. 2023 ($310.5 Mil) to Dec. 2023 ($3.2 Mil) but then increased from Dec. 2023 ($3.2 Mil) to Jun. 2024 ($464.7 Mil).

Akeso's annual Other Gross PPE increased from Dec. 2021 ($1.2 Mil) to Dec. 2022 ($1.6 Mil) and increased from Dec. 2022 ($1.6 Mil) to Dec. 2023 ($3.2 Mil).

Akeso Other Gross PPE Historical Data

The historical data trend for Akeso's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Other Gross PPE Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial 0.39 0.46 1.24 1.55 3.16

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 255.64 1.55 310.46 3.16 464.69

Akeso Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Akeso Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Other Gross PPE
Comparable Companies
HKSE:01801 HKSE:01177 HKSE:06990 HKSE:02269 HKSE:01877 HKSE:01548 HKSE:02410 HKSE:01952 HKSE:01530 HKSE:06855 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
09926:Hong Kong 4RY:Germany
Address
6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Website
https://www.akesobio.com
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.